Efficacy and safety of rituximab second-line therapy for membranous nephropathy: A prospective, matched-cohort study

Paolo Cravedi, Maria Chiara Sghirlanzoni, Maddalena Marasà, Alessandra Salerno, Giuseppe Remuzzi, Piero Ruggenenti

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Efficacy and safety of rituximab second-line therapy for membranous nephropathy: A prospective, matched-cohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences